Simultaneous determination of valsartan and hydrochlorothiazide in tablets by high-performance liquid chromatography

被引:36
作者
Carlucci, G [1 ]
Di Carlo, V [1 ]
Mazzeo, P [1 ]
机构
[1] Univ Aquila, Dipartimento Chim Ingn Chim & Mat, I-67010 Coppito, LAquila, Italy
关键词
HPLC; valsartan; hydrochlorothiazide; simultaneous determination;
D O I
10.1080/00032710008543204
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A method for the simultaneous determination of valsartan and hydrochlorothiazide in tablets is described. The procedure, based on the use of reversed-phase high-performance liquid chromatography, is linear in the concentration range 5.0-10.0 mu g ml(-1) for valsartan and 0.5-2.0 mu g ml(-1) for hydrochlorothiazide, is simple and rapid and allows accurate and precise results. The limit of detection was 1.0 mu g ml(-1) for valsartan and 0.05 mu g ml(-1) for hydrochlorothiazide.
引用
收藏
页码:2491 / 2500
页数:10
相关论文
共 18 条
[1]   Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy [J].
Benz, JR ;
Black, HR ;
Graff, A ;
Reed, A ;
Fitzsimmons, S ;
Shi, Y .
JOURNAL OF HUMAN HYPERTENSION, 1998, 12 (12) :861-866
[2]   SIMULTANEOUS DETERMINATION OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE IN TABLETS BY DERIVATIVE UV SPECTROPHOTOMETRY AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
CARLUCCI, G ;
DIGIUSEPPE, E ;
MAZZEO, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 93 (1-3) :245-248
[3]   Long-term efficacy, safety, and tolerability of valsartan and hydrochlorothiazide in patients with essential hypertension [J].
Chrysant, SG ;
Wombolt, DG ;
Feliciano, N ;
Zheng, HJ .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (11) :762-772
[4]  
CIERI UR, 1994, J AOAC INT, V77, P1104
[5]  
Deppeler H.P., 1981, Analytical Profiles of Drug Substances, V10, P405, DOI [10.1016/S0099-5428(08)60646-2, DOI 10.1016/S0099-5428(08)60646-2]
[6]   SIMULTANEOUS DETERMINATION OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE BY FIRST-DERIVATIVE ULTRAVIOLET SPECTROPHOTOMETRY AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ELWALILY, AFM ;
BELAL, SF ;
HEABA, EA ;
ELKERSH, A .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (07) :851-856
[7]  
Erk N, 1997, ANALUSIS, V25, P161
[8]   Determination of active ingredients in the pharmaceutical formulations containing hydrochlorothiazide and its binary mixtures with benazepril hydrochloride, triamterene and cilazapril by ratio spectra derivative spectrophotometry and vierordt's method [J].
Erk, N .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 20 (1-2) :155-167
[9]  
Erram S., 1992, INDIAN DRUGS BOMBAY, V29, P553
[10]   Efficacy and tolerability of valsartan in combination with hydrochlorothiazide in essential hypertension [J].
Hall, WD ;
Montoro, R ;
Littlejohn, T ;
Jain, A ;
Feliciano, N ;
Zheng, HJ .
CLINICAL DRUG INVESTIGATION, 1998, 16 (03) :203-210